ROC analysis indicated that is possible to discriminate between non-cancerous samples from those of invasive cervical cancer with a higher sensitivity (~98%; Supplementary Fig. S4), than the 55% reported for the pap smear test35, meaning that SCN8A gene levels could be more effective in identifying true positive cases that the typical pap smear test. This evidence concerns the gene SCN8A and cervical carcinoma.